Assignee profile:

COSMO TECHNOLOGIES LTD.

City:

Dublin 2

Country:

Ireland

Published Applications:

21

Last publication date:

2025-12-11

Patent Grants:

10

Last grant date:

2024-07-16

Top Inventors for applications by COSMO TECHNOLOGIES LTD.

These are the the leading inventors for applications assigned to COSMO TECHNOLOGIES LTD.:

Recent patent applications by COSMO TECHNOLOGIES LTD.

COSMO TECHNOLOGIES LTD. based in Dublin 2, IE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-11
US20250375381A1
Human necessities

Compositions and methods for treating bile acid malabsorption

#2 | 2025-08-21
US20250262165A1
Human necessities

Compositions and methods for treating bile acid malabsorption

#3 | 2025-06-12
US20250186626A1
Human necessities

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

#4 | 2024-12-05
US20240398699A1
Human necessities

ORAL RIFAMYCIN SV COMPOSITIONS

#5 | 2024-08-22
US20240277731A1
Human necessities

17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS

#6 | 2023-05-04 ✅ Patent 12,036,316 granted on 2024-07-16
US20230135346A1
Human necessities

Oral rifamycin SV compositions

#7 | 2023-04-27
US20230130628A1
Human necessities

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

#8 | 2023-04-27 ✅ Patent 11,986,484 granted on 2024-05-21
US20230128438A1
Human necessities

17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors

#9 | 2021-05-27 ✅ Patent 12,011,483 granted on 2024-06-18
US20210154300A1
Human necessities

Liquid delivery composition

#10 | 2021-01-14
US20210007993A1
Human necessities

SOLID DELIVERY COMPOSITION

#11 | 2020-09-10 ✅ Patent 11,564,883 granted on 2023-01-31
US20200281850A1
Human necessities

Oral rifamycin SV compositions

#12 | 2020-07-09 ✅ Patent 10,993,949 granted on 2021-05-04
US20200215080A1
Human necessities

17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors

#13 | 2020-04-30
US20200129643A1
Human necessities

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

#14 | 2020-02-27
US20200061212A1
Human necessities

SOLID ORAL COMPOSITION CONTAINING DYES

#15 | 2019-06-27
US20190192441A1
Human necessities

ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS

#16 | 2019-06-13
US20190175618A1
Human necessities

17ALPHA-MONOESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS

#17 | 2019-03-28 ✅ Patent 10,646,497 granted on 2020-05-12
US20190091240A1
Human necessities

17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors

#18 | 2018-08-23 ✅ Patent 10,413,611 granted on 2019-09-17
US20180236087A1
Human necessities

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

#19 | 2017-02-16 ✅ Patent 9,962,445 granted on 2018-05-08
US20170043018A1
Human necessities

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

#20 | 2016-10-13 ✅ Patent 9,987,366 granted on 2018-06-05
US20160296659A1
Human necessities

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

#21 | 2016-09-08 ✅ Patent 9,522,216 granted on 2016-12-20
US20160256594A1
Human necessities

Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection

Also check out COSMO TECHNOLOGIES LTD.'s (Dublin 2, Ireland) applicant profile with 5 patent applications submitted.

AssigneeID:

112765 ⎘